Literature DB >> 4119160

Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

E Plow, T S Edgington.   

Abstract

Physiological degradation of fibrinogen by plasmin leads to a recognized series of intermediate and stable terminal cleavage fragments and is associated with complex modulation and progressive loss of native antigenic expressions. Early in association with progressive plasmin cleavage, a stable cleavage-associated neoantigen, present in the D-fragment region of the molecule, is exposed in vitro and can be recognized by competitive inhibition radioimmunoassay with specific antiserum. It is demonstrated that there is an approximate equimolar expression of the cleavage-associated neoantigen. fg-D(neo), on the X-, Y-, and D-fragments and no recognizable (< 10(-3)) expression by fibrinogen or by the E-fragment. The X-fragment contains two D regions in respect to total D-fragment-associated antigenic expressions but unitary expression of fg-D(neo) is observed. The Y-fragment appears to contain one D-fragment region in respect to total D-fragment-associated antigens and exhibits close to unitary expression of fg-D(neo). Terminal cleavage digests containing the D- and E-fragments exhibit more than 10-fold greater native fibrinogen antigenic expression than the sum of the constituent fragments. This suggests the presence of a non-covalently associated native complex of the D- and E-fragments, and implies contiguity of the D- and E-fragments in the native fibrinogen molecule. The cleavage-associated neoantigen, fg-D(neo), is also generated in vivo and is generically demonstrable in the plasma of patients with various forms of in vivo fibrinolysis. These studies offer a precise immunochemical system, based upon defined molecular events, for the investigation of physiological and pathophysiological cleavage of fibrinogen. By contrast with other approaches to the assay of in vitro or in vivo cleavage of fibrinogen, assay of the cleavage-associated neoantigen fg-D(neo) is specific, sensitive, directly yields the molar concentration of all cleavage fragments except E, and is directly applicable to plasma.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4119160      PMCID: PMC302256          DOI: 10.1172/JCI107183

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties].

Authors:  V NUSSENZWEIG; M SELIGMANN; J PELMONT; P GRABAR
Journal:  Ann Inst Pasteur (Paris)       Date:  1961-03

2.  Fibrinolysis in metastatic cancer of the prostate.

Authors:  H J TAGNON; W F WHITMORE; N R SHULMAN
Journal:  Cancer       Date:  1952-01       Impact factor: 6.860

3.  A new method for the determination of fibrinogen in small samples of plasma.

Authors:  O D RATNOFF; C MENZIE
Journal:  J Lab Clin Med       Date:  1951-02

4.  The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally.

Authors:  A P Fletcher; N Alkjaersig; S Fisher; S Sherry
Journal:  J Lab Clin Med       Date:  1966-11

5.  Neoantigenic expressions engendered by plasmin cleavage of fibrinogen.

Authors:  E F Plow; C Hougie; T S Edgington
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

6.  Structure and in vivo behavior of human fibrinogen fragment-D.

Authors:  A Catanzaro; G Hathaway; J Strathern; T Edgington; W O Weigle
Journal:  Proc Soc Exp Biol Med       Date:  1972-04

7.  Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

Authors:  M W Mosesson; J S Finlayson; R A Umfleet; D Galanakis
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

8.  The effect of plasmin on the subunit structure of human fibrinogen.

Authors:  S V Pizzo; M L Schwartz; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1972-02-10       Impact factor: 5.157

Review 9.  Infection and disseminated intravascular coagulation.

Authors:  T Yoshikawa; K R Tanaka; L B Guze
Journal:  Medicine (Baltimore)       Date:  1971-07       Impact factor: 1.889

10.  Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation).

Authors:  E Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

View more
  13 in total

1.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.

Authors:  M J Martin; Y B Gordon; S M Ratky; L R Baker; T Chard
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

3.  The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays.

Authors:  A Molla; M B Donati; J Vermylen
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

4.  Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.

Authors:  E F Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

5.  The number of D and E regions in the fibrinogen molecule.

Authors:  E F Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

6.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors:  E F Plow
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Combined functional and immunochemical analysis of normal and abnormal human factor X.

Authors:  D S Fair; E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets.

Authors:  J D Wencel-Drake; E F Plow; T S Zimmerman; R G Painter; M H Ginsberg
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.